# SR One

SR One is a Private Equity based in Redwood City, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Redwood City, United States
- **Region:** North America
- **Address:** Redwood City, CA, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** www.srone.com
- **LinkedIn:** https://www.linkedin.com/company/sr-one

## Regulatory record

- **Reports private funds:** No

## About

SR One is a biotechnology venture capital firm founded in 1985 in Redwood City, California. It partners with founders and entrepreneurs to translate science into medicines. SR One has made 340 investments and has a presence in several countries.

## Sectors

- Biotechnology

## Offices

- London, United Kingdom

## Questions

### What is SR One's investment strategy?

SR One employs a back-and-build venture capital model targeting biotechnology companies across development stages from seed to late stage. The firm focuses on novel scientific approaches with clear therapeutic pathways, spanning multiple modalities and indications. Investments range from preclinical startups to public clinical-stage companies.

### Where does SR One invest geographically?

SR One maintains a transatlantic footprint with offices in Redwood City, California, and London, UK. The firm sources opportunities across the US West Coast and European biotech ecosystems. This dual-hub structure is designed to provide portfolio companies with regional expertise and access to capital on both sides of the Atlantic.

### What therapeutic areas does SR One target?

The firm invests across a broad range of therapeutic areas, including oncology, immunology, cardiometabolic disease, CNS disorders, rare diseases, infectious disease, renal conditions, neuropsychiatry, hematology, and rheumatology. This multi-indication scope reflects a platform-agnostic approach to drug development.

### What is the firm's relationship with GSK?

The SR One team originally functioned within GSK as a corporate venture group. Certain portfolio investments listed on the firm's website were made during that legacy period and are not held in the current independent funds. The firm now operates independently from GSK, managing its own fund vehicles.

## Related profiles

- [SRN Advisors](https://altss.com/profile/srn-advisors)
- [S. R. Schill & Associates](https://altss.com/profile/s-r-schill-associates)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sr-one

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology